22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
While U.S. lawmakers grapple with the dynamics of the gig economy, our neighbor to the north is witn...
Read More >
Amid the exponential increase of COVID-19 cases in the State of New York and, more specifically in N...
Read More >
With the increase in communication and notices being sent to customers in multiple industries, one a...
Read More >
Proposed regulations, if adopted, would impose substantial restrictions in many cases on a corporati...
Read More >
This year there were a number of significant legislative changes to the Virginia Stock Corporation A...
Read More >
The gig economy is the future of the workforce, right? Or is it an old concept with a modern twist? ...
Read More >